(Q84548077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Chemotherapy: Standardizing the care of invasive bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

12 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

454-455

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.109

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21750504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2011.109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21750504%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference